Friday, October 30, 2009: 11:30 AM-2:30 PM
Chair:
Discussant:
32.1
Candidate Gene Analysis of Methylphenidate Response in ADHD
James J. McGough, M.D.
University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Sandra K. Loo, Ph.D.
University of California at Los angeles, Los Angeles, CA
James T. McCracken, M.D.
University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
32.2
Genome Wide Association Study of Methylphenidate Transdermal System
Eric Mick, Ph.D.
Massachusetts General Hospital, Boston, MA
32.3
Dopamine Genes and Weight Gain in Autistic Children Treated with Risperidone
James T. McCracken, M.D.
University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Michael G. Aman, Ph.D.
Ohio State University, Columbus, OH
Christopher J. McDougle, M.D.
Indiana University School of Medicine, Indianapolis, IN
Larry Scahill, Ph.D., M.S.N.
Yale Child Study Center, New Haven, CT
Elaine Tierney, M.D.
Kennedy Krieger Institute, Baltimore, MD
L. Eugene Arnold, M.D.
Ohio State University, Nisonger Center UCEDD, Sunbury, OH
Fiona Whelan, M.S.
University of California at Los Angeles Semel Institute for Neuroscience & Human Behavior, Los Angeles, CA
Benedetto Vitiello, M.D.
National Institute of Mental Health (NIMH), Bethesda, MD
32.4
Pharmacogenetic Predictors of Suicide Risk
David A. Brent, M.D.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA